11:08 AM EST, 02/26/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.80% to 1,430.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and brewing company Anheuser-Busch InBev ( BUD ) , which climbed 11.3% and 8.9% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Cellectis ( CLLS ) , which increased 3.7% and 3.6% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and semiconductor company Sequans Communications ( SQNS ) , which fell 0.7% and 0.5% respectively. They were followed by telecommunications company Nokia ( NOK ) and internet advertising firm Criteo ( CRTO ) , which were off 0.5% and 0.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Bicycle Therapeutics ( BCYC ) and Biodexa Pharmaceuticals ( BDRX ) , which rose 4.8% and 4.4% respectively. They were followed by financial services company Lloyds Banking Group ( LYG ) and medical device maker Smith & Nephew ( SNN ) , which were up 4.1% and 3.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Adaptimmune Therapeutics ( ADAP ) , which lost 7.8% and 2.6% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which were down 0.8% and 0.6% respectively.